Trial
NCT03092791
IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Poliomyelitis
Intervention
Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV)
Why stopped
Planned immunogenicity outcomes not reached
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-31